SCHEMBL6901463

SCHEMBL6901463

NC(CO)CCC(N)CO

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ENPEP Q07075 1/20 0.33
THRB P10828 1/20 0.32
TSHR P16473 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13330727 0.87
SCHEMBL5822180 0.85
SCHEMBL59325 0.85
SCHEMBL1604993 0.85
SCHEMBL24177897 0.84
SCHEMBL10211187 0.84
SCHEMBL11116754 0.84
SCHEMBL2354479 0.82 LMNA (0.36) TSHRALDH1A1LMNA
SCHEMBL74076 0.82
SCHEMBL15899316 0.82 THRB (0.40) THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9949484-B2 Antimicrobial polyurethane materials and methods of forming and using same THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2018-04-24 US claimed
US-20150132248-A1 ANTIMICROBIAL POLYURETHANE MATERIALS AND METHODS OF FORMING AND USING SAME THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE 2015-05-14 US claimed
WO-2013166198-A1 ANTIMICROBIAL POLYURETHANE MATERIALS AND METHODS OF FORMING AND USING SAME THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2013-11-07 WO claimed
CN-115152007-A Solder bump forming member, method for manufacturing solder bump forming member, and method for manufacturing solder bump-attached electrode substrate 昭和电工材料株式会社 2022-10-04 CN disclosed
US-9949484-B2 Antimicrobial polyurethane materials and methods of forming and using same THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2018-04-24 US disclosed
US-20150132248-A1 ANTIMICROBIAL POLYURETHANE MATERIALS AND METHODS OF FORMING AND USING SAME THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE 2015-05-14 US disclosed
WO-2013166198-A1 ANTIMICROBIAL POLYURETHANE MATERIALS AND METHODS OF FORMING AND USING SAME THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2013-11-07 WO disclosed
EP-0982385-B1 ADHESIVE, METHOD FOR BONDING, AND ASSEMBLIES OF MOUNTED BOARDS FUJITSU LTD (JP) 2004-01-28 EP disclosed
US-6576081-B2 Two-pack adhesive; A contains components selected from one or more acrylic monomers, peroxide, reducing agent, epoxy resin precursor and curing agent; B contains all of the remaining components which are not selected in A FUJITSU LIMITED (JP) 2003-06-10 US disclosed
US-20020084019-A1 Two-pack adhesive; A contains components selected from one or more acrylic monomers, peroxide, reducing agent, epoxy resin precursor and curing agent; B contains all of the remaining components which are not selected in A FUJITSU LIMITED (JP) 2002-07-04 US disclosed
EP-0982385-A1 ADHESIVE, METHOD FOR BONDING, AND ASSEMBLIES OF MOUNTED BOARDS FUJITSU LIMITED (JP) 2000-03-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150132248-A1 ANTIMICROBIAL POLYURETHANE MATERIALS AND METHODS OF FORMING AND USING SAME PUF60, UFL1, CUTA ENPEP 4215/4885THRB 4680/4885TSHR 4732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.